asp0739
Showing 1 - 1 of 1
Ovarian Cancer, NSCLC, ESCC Trial in United States (ASP0739, Pembrolizumab)
Active, not recruiting
- Ovarian Cancer
- +3 more
- ASP0739
- Pembrolizumab
-
Duarte, California
- +6 more
Jan 21, 2023